
Gene Expression Profiling of Breast Cancer Brain Metastases – Mirrors of Medicine
Mirrors of Medicine shared a post on X, about a recent article by G. Griguolo et al published in ESMO Open:
“Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications
This study investigated the genomic landscape of breast cancer brain metastases (BCBMs) by comparing them with matched primary breast tumors to better understand the biological evolution during metastasization.
Analysis revealed a high prevalence of non-luminal subtypes in BCBMs, particularly HER2-enriched and basal-like profiles, even among tumors originally classified as luminal or hormone receptor-positive/HER2-negative.
A notable shift toward the HER2-enriched subtype was observed in brain metastases, accompanied by recurrent changes in gene expression, including alterations in genes related to cell survival, migration, HER2 signaling, and endocrine response.”
Title: Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications
Authors: G. Griguolo, M.V. Dieci, S. Fineberg, C. Pinato, M. Bottosso, L. Bauchet, F. Miglietta, J. Jacob, V. Rigau, M.C. Guarascio, F. Zanconato, F. Schiavi, M. Fassan, A.P. Dei Tos, W. Jacot, S. Piccolo, A. Darlix, V. Guarneri
Read the Full Article on ESMO Open
More posts featuring Breast Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023